Actively Recruiting
Evaluating Endovascular Therapy Plus Medical Management Versus Medical Management Alone for Acute Basilar Artery Occlusion with Large Ischemic Core
Led by The First Affiliated Hospital of University of Science and Technology of China · Updated on 2026-10-13
256
Participants Needed
1
Research Sites
22 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are investigating the benefits and risks of endovascular therapy combined with best medical management compared to best medical management alone for patients experiencing acute basilar artery occlusion with a large ischemic core. This condition is linked to high death rates and severe disability, and prior studies have shown benefits of endovascular therapy in selected patients, but those with large ischemic cores have not been well represented. This trial aims to assess functional outcomes 90 days after treatment in patients treated within 24 hours of symptom onset or last known well. Participants aged 18 to 85 years with confirmed basilar artery occlusion and low pc-ASPECTS scores will be randomly assigned to one of two groups. One group will receive endovascular therapy, which may include mechanical thrombectomy techniques like stent retriever or direct aspiration, in addition to best medical management that follows current stroke guidelines. The other group will receive best medical management alone, which may include intravenous thrombolysis and supportive stroke care. Randomization will be stratified by factors such as stroke severity and time from symptom onset. During the study, participants will be evaluated through neurological assessments, imaging studies including CT or MRI scans, and functional outcome measures like the modified Rankin Scale at 90 days. Safety will be monitored by tracking hemorrhages, mortality, and adverse events. Secondary measures will assess quality of life and stroke severity changes. The overall participation may last up to 90 days after randomization, with follow-up visits focused on measuring recovery and safety.
CONDITIONS
Brief Title
Endovascular Therapy for Acute Basilar Artery Occlusion With Large Ischemic Core
Research Team
C
Chunrong Tao, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here